Viewing Study NCT03854903


Ignite Creation Date: 2025-12-24 @ 7:16 PM
Ignite Modification Date: 2025-12-30 @ 2:07 PM
Study NCT ID: NCT03854903
Status: COMPLETED
Last Update Posted: 2025-02-06
First Post: 2019-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor
Sponsor: Georgetown University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module